Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DBV

DBV Technologies (DBV)

DBV Technologies
Date:
Sort by:
 Showing the most relevant articles for your search:EU:DBV
DateTimeSourceHeadlineSymbolCompany
12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
10/20/20224:30PMGlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022EU:DBVDBV Technologies
10/20/20224:30PMGlobeNewswire Inc.Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2022EU:DBVDBV Technologies
10/20/20224:30PMGlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022EU:DBVDBV Technologies
10/03/20224:30PMGlobeNewswire Inc.DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of DirectorsEU:DBVDBV Technologies
10/03/20224:30PMGlobeNewswire Inc.DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of DirectorsEU:DBVDBV Technologies
10/03/20224:30PMGlobeNewswire Inc.DBV Technologies annonce la nomination du nouveau Président de son Comité d’Audit et de Danièle Guyot-Caparros au Conseil d’AdministrationEU:DBVDBV Technologies
09/21/20225:45PMGlobeNewswire Inc.DBV Technologies fait le point sur l’étude clinique de phase 3 VITESSEEU:DBVDBV Technologies
09/21/20225:45PMGlobeNewswire Inc.DBV Technologies Provides Clinical Update on VITESSE Phase 3 TrialEU:DBVDBV Technologies
09/21/20225:45PMGlobeNewswire Inc.DBV Technologies Provides Clinical Update on VITESSE Phase 3 TrialEU:DBVDBV Technologies
09/07/20224:30PMGlobeNewswire Inc.DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7 YearsEU:DBVDBV Technologies
09/07/20224:30PMGlobeNewswire Inc.DBV Technologies annonce le lancement de l’étude de phase 3 (VITESSE) portant sur le patch Viaskin Peanut modifié chez les enfants allergiques à l’arachide âgés de 4 à 7 ansEU:DBVDBV Technologies
09/07/20224:30PMGlobeNewswire Inc.DBV Technologies Announces Initiation of Phase 3 Study (VITESSE) Using the Modified Viaskin Peanut Patch in Peanut -Allergic Children Ages 4 to 7 YearsEU:DBVDBV Technologies
09/02/20224:30PMGlobeNewswire Inc.DBV Technologies to Present at Upcoming Investor ConferencesEU:DBVDBV Technologies
09/02/20224:30PMGlobeNewswire Inc.DBV Technologies invité à présenter lors des prochaines conférences investisseursEU:DBVDBV Technologies
09/02/20224:30PMGlobeNewswire Inc.DBV Technologies to Present at Upcoming Investor ConferencesEU:DBVDBV Technologies
08/10/20224:50PMGlobeNewswire Inc.Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy SpaceEU:DBVDBV Technologies
08/01/20224:30PMGlobeNewswire Inc.DBV Technologies Reports Second Quarter 2022 Financial ResultsEU:DBVDBV Technologies
08/01/20224:30PMGlobeNewswire Inc.DBV Technologies Reports Second Quarter 2022 Financial ResultsEU:DBVDBV Technologies
08/01/20224:30PMGlobeNewswire Inc.DBV Technologies publie ses résultats financiers du deuxième trimestre 2022EU:DBVDBV Technologies
07/27/20224:30PMGlobeNewswire Inc.Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHFEU:DBVDBV Technologies
07/27/20224:30PMGlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFEU:DBVDBV Technologies
07/27/20224:30PMGlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFEU:DBVDBV Technologies
07/20/20224:30PMGlobeNewswire Inc.Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 30 juin 2022EU:DBVDBV Technologies
07/20/20224:30PMGlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022EU:DBVDBV Technologies
07/20/20224:30PMGlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2022EU:DBVDBV Technologies
06/28/20226:15PMGlobeNewswire Inc.DBV Technologies to Participate in Upcoming EAACI 2022 CongressEU:DBVDBV Technologies
06/28/20226:15PMGlobeNewswire Inc.DBV Technologies to Participate in Upcoming EAACI 2022 CongressEU:DBVDBV Technologies
06/16/20221:30AMGlobeNewswire Inc.DBV Technologies invitée à présenter à la conférence JMP Securities Life Sciences à New YorkEU:DBVDBV Technologies
06/16/20221:30AMGlobeNewswire Inc.DBV Technologies to Present at the JMP Securities Life Sciences Conference in New YorkEU:DBVDBV Technologies
 Showing the most relevant articles for your search:EU:DBV

Your Recent History

Delayed Upgrade Clock